Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial
Author:
Funder
Deutsche Forschungsgemeinschaft
José Carreras Leukämie-Stiftung
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00432-019-02961-9.pdf
Reference27 articles.
1. Blaker YN, Spetalen S, Brodtkorb M et al (2016) The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era. Br J Haematol 175:102–114. https://doi.org/10.1111/bjh.14201
2. Canioni D, Salles G, Mounier N et al (2008) High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. J Clin Oncol 26:440–446. https://doi.org/10.1200/jco.2007.12.8298
3. Carbone A, Gloghini A, Cabras A, Elia G (2009) The Germinal centre-derived lymphomas seen through their cellular microenvironment. Br J Haematol 145:468–480. https://doi.org/10.1111/j.1365-2141.2009.07651.x
4. Dave SS, Wright G, Tan B et al (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351:2159–2169
5. Du J, Lopez-Verges S, Pitcher BN et al (2014) CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells. Cancer Immunol Res 2:878–889. https://doi.org/10.1158/2326-6066.cir-13-0158
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tumor-associated macrophages in lymphoma: From mechanisms to therapy;International Immunopharmacology;2022-11
2. Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy;British Journal of Haematology;2020-02-03
3. The life and death of the germinal center;Annals of Diagnostic Pathology;2020-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3